These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2386496)

  • 21. [The effect of recombinant human erythropoietin during hemodialysis on the thrombocyte and erythrocyte functions of patients with chronic kidney failure].
    Rud'ko IA; Balashova TS; Kubatiev AA; Ermolenko VM
    Ter Arkh; 1994; 66(6):57-60. PubMed ID: 7940371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C; Blumberg A
    Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human erythropoietin administration improves thiamine content in blood and erythrocytes transketolase activity in pre-dialyzed patients.
    Pietrzak I; Baczyk K; Kubiak W
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():29-37. PubMed ID: 8192530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of erythropoietin treatment on tissue oxygenation in patients with severe transfusion dependent renal anaemia.
    Landgraf H; Grützmacher P; Garcia-Bartels C; Bergmann M; Ehrly AM; Schoeppe W
    Eur J Med; 1993; 2(7):393-7. PubMed ID: 8258026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life.
    Nissenson AR
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):25-31. PubMed ID: 2669083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
    Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
    Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Has recombinant human erythropoietin therapy minimized red-cell transfusions in hemodialysis patients?
    Goodnough LT; Strasburg D; Riddell J; Verbrugge D; Wish J
    Clin Nephrol; 1994 May; 41(5):303-7. PubMed ID: 8050211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of recombinant human erythropoietin on the rate of Na+,H+-exchange in erythrocytes of patients with chronic kidney insufficiency treated by hemodialysis].
    Kubatiev AA; Rud'ko IA; Ermolenko VM
    Biull Eksp Biol Med; 1997 Dec; 124(12):613-5. PubMed ID: 9483309
    [No Abstract]   [Full Text] [Related]  

  • 31. [Erythropoietin--the first hematologic hormone in clinical use].
    Rhyner K
    Schweiz Med Wochenschr; 1988 Mar; 118(11):375-80. PubMed ID: 3287601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of erythropoietin on strength and functional status of patients on hemodialysis.
    Guthrie M; Cardenas D; Eschbach JW; Haley NR; Robertson HT; Evans RW
    Clin Nephrol; 1993 Feb; 39(2):97-102. PubMed ID: 8448925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients.
    Riedel E; Hampl H; Scigalla P; Nündel M; Kessel M
    Kidney Int Suppl; 1989 Nov; 27():S216-21. PubMed ID: 2636662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Individual differences in the efficacy of Recormon in patients with terminal kidney failure. The role of iron deficiency].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kondakhchan MA; Rogov VA; Trofimova EI
    Ter Arkh; 1993; 65(6):45-8. PubMed ID: 8378849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration].
    Stutz B; Rhyner K; Vögtli J; Binswanger U
    Schweiz Med Wochenschr; 1987 Sep; 117(38):1397-402. PubMed ID: 3672079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epoetin: human recombinant erythropoietin.
    Flaharty KK; Grimm AM; Vlasses PH
    Clin Pharm; 1989 Nov; 8(11):769-82. PubMed ID: 2680241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating haematopoietic progenitors during treatment of renal anaemia with recombinant human erythropoietin.
    Göbel V; Hoffmann HG; Müller-Wiefel DE; Braun A; Ludwig R; Schärer K; Debatin KM
    Eur J Pediatr; 1994 Jan; 153(1):43-8. PubMed ID: 8313924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of renal anaemia with recombinant human erythropoietin results in decreased red cell uptake of 45Ca.
    Linde T; Ronquist G; Sandhagen B; Wikström B; Frithz G; Pettersson L; Danielson BG
    Nephron; 1994; 68(4):419-26. PubMed ID: 7870225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human erythropoietin in the diabetic patient.
    Friedman EA; Delano BG
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):35-9. PubMed ID: 2192415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.